LifeLabs, Contextual to Co-market, Sell Genetic Tests in Canada | GenomeWeb

NEW YORK (GenomeWeb News) – LifeLabs Medical Laboratory Services and Contextual Genomics today announced a deal to broaden the availability of Contextual's genetic and genomic tests in Canada.

Under the terms of the agreement, the companies will co-market and sell Contextual's genetic tests for cancer and other conditions to patients and doctors in Canada. Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.